期刊
MOLECULAR BIOLOGY REPORTS
卷 49, 期 3, 页码 2433-2442出版社
SPRINGER
DOI: 10.1007/s11033-021-07009-1
关键词
Anti-inflammatory cytokines; Sickle cell disease; Pathophysiology; Chronic inflammation
资金
- National Council for Scientific and Technological Development (CNPq) [190374/2017]
- Teaching, Research Support Fund
- Extension-FAEPEX/UNICAMP Brazil [3386/19]
- Coordination for the Improvement of Higher Education Personnel (CAPES)
Sickle cell disease is a well-studied monogenetic disease characterized by chronic inflammation. Recent studies have shown an imbalance between pro-inflammatory and anti-inflammatory cytokines in patients with sickle cell disease. This review improves understanding of the pathophysiology of the disease and offers insights for the development of new therapeutic options.
Sickle cell disease (SCD) is a well-studied monogenetic disease with an established chronic inflammatory component. The paradigm shift towards inflammation has made the pathophysiology of SCD even more complex. Studies have shown that an imbalance between the pro-inflammatory and anti-inflammatory cytokines in SCD exists; however, the reports are skewed toward the pro-inflammatory mediators. We enumerate recent in vitro and in vivo studies on anti-inflammatory cytokines in SCD patients, and discuss the biology of anti-inflammatory cytokines including the already reported IL-2, TGF-beta, and IL-10 as well as the recently discovered IL-27, IL-35 and IL-37. This review will improve the understanding of the pathophysiology of SCD and aid in the search of new therapeutic options for patients with SCD.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据